A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)

NCT06627322 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

5950

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Dual-combination therapy
DRUG: Triple-combination therapy
DEVICE: Dexcom G7, Pasta

Sponsor

Kyu Chang Won

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]